Eli Lilly accused of bribing providers to prescribe GLP-1RA drugs
Attorney General Ken Paxton sued pharmaceutical giant Eli Lilly for bribing and illegally inducing medical providers to prescribe its most profitable drugs
Attorney General Ken Paxton sued pharmaceutical giant Eli Lilly for bribing and illegally inducing medical providers to prescribe its most profitable drugs
These filings come after FDA issued its latest warning to patients and healthcare professionals about the serious dangers of compounded GLP-1 drugs
During Q1FY26, the company incurred Capex of ~Rs. 48.5 crores mainly towards capacity expansion, backward integration and finished formulation R&D
The company recorded its quarterly consolidated revenue from operations at Rs. 61.22 crore in Q4 FY25
The company has posted net profit of Rs.168.16 crores for the Financial Year ended March 31, 2025
The consignment of USFDA qualified Metformin (1000mg) was received by the province of Mendoza for distribution in the public health system
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
The FDA determined that the data presented in a 2022 color additive petition show that this ingredient causes cancer in male laboratory rats exposed to high levels of FD&C Red No. 3 because of a hormonal mechanism that occurs in male rats
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
Subscribe To Our Newsletter & Stay Updated